Lakefront Biotherapeutics | GLPG - Stock





Stock Veränderung Datum
argenx SE USD 473.53M 132.91M 2025-12
AstraZeneca USD 6.93B 362M 2026-06
Biogen USD 2.38B 435.3M 2026-06
Genmab DKK 21M 8M 2026-03
Gilead Sciences USD 1.91B 140M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
GRIFOLS EUR 3.49B 34M 2026-06
Hikma Pharmaceutical USD 1.11B 24M 2025-12
Incyte USD 112.54M 3.08M 2026-06
Merck EUR 4.78B 220M 2026-03
Neurocrine Biosciences USD 104.2M 39.7M 2026-06
Novartis USD 6.22B 66M 2026-06
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 24.12B 620M 2026-06
UCB EUR 1.31B 173M 2024-12
Vertex Pharmaceuticals USD 1.77B 1.6M 2026-06